UK tissue converter Accrol Papers appoints Chris Welsh to its board as new CFO; Welsh succeeds Richard Newman, who has resigned as CFO and stepped down from the board but will stay with Accrol until FY23 audit process is completed, final results released

Sample article from our Tissue & Hygiene

May 5, 2023 (press release) –

Appointment of new Chief Financial Officer


Accrol, the UK's leading independent tissue converter, is pleased to announce that Chris Welsh has today joined the Board as Chief Financial Officer ("CFO").


As detailed in the HY23 Results announcement, Chris succeeds Richard Newman, who has now resigned as CFO and stepped down from the Board but, to ensure a smooth transition, has agreed to remain with the Company until the FY23 audit process is completed and the Final Results are released.


Chris joined the business in October 2022, as part of the Board's succession planning. Before his move to Accrol, Chris held several senior finance roles at the multinational chemical manufacturing group, Ineos, most latterly as Head of Financial Reporting at the Enterprises Division.


Chris is a Chartered Accountant, who qualified with PwC in 2015.


Gareth Jenkins, Chief Executive Officer, said:


"We are delighted to welcome Chris to the Board. Since joining Accrol last year, he has been operating at the highest standard, demonstrating the commitment, energy and acumen which will help deliver our strategic objectives.


"I would also like to take this opportunity to thank Richard for his significant contribution to the Group. On appointment, he was tasked with transforming the finance function of the business, which he has achieved. Richard hands over to Chris a much strengthened finance team and infrastructure, capable of serving a much larger business."


Further information relating to Christopher Welsh


In accordance with Schedule 2(g) of the AIM rules, Christopher ("Chris") James Welsh (aged 33) holds or has held in the past five years the following directorships:


Current directorships



Accrol UK Limited


LTC Parent Ltd


John Dale Holdings Limited


Leicester Tissue Company Limited


Art Tissue Ltd


Accrol Papers Limited


Accrol Holdings Limited


John Dale Limited


Chris holds no shares in the Company.


There is no further information on Chris required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.


For further information, please contact:




Accrol Group Holdings plc


Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer


Chris Welsh, Chief Financial Officer




Zeus (Nominated Adviser & Broker) 


Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000



Shore Capital Stockbrokers (Joint Broker)

Tel: +44 (0) 20 7408 4090

Malachy McEntyre / Mark Percy / James Thomas




Belvedere Communications Limited


Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525


Overview of Accrol


Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which together supply c.21.5% (volume) of the UK tissue market valued at c£2.5bn at retail sales value.


For more information, please visit


Link for Accrol Today video:

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.